Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Thrombosis and Haemostasis|April 2, 1999
Clinical prediction of deep vein thrombosis in patients with leg symptomsS R Kahn, L Joseph, L Abenhaim, et al.Current Oncology (Toronto, Ont.)|August 5, 2014
Bortezomib in multiple myeloma: systematic review and clinical considerationsT C Kouroukis, F G Baldassarre, A E Haynes, et al.Thrombosis Research|February 15, 1986
Management of anti-thrombin III deficiency during pregnancy without administration of anti-thrombin IIIJ R Leclerc, W Geerts, A Panju, et al.Thrombosis Research|April 27, 2001
A randomized management study of impedance plethysmography vs. contrast venography in patients with a first episode of clinically suspected deep vein thrombosisS R Kahn, L Joseph, S A Grover, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1988
Technetium-99m red blood cell venography in patients with clinically suspected deep vein thrombosis: a prospective studyJ R Leclerc, C Wolfson, A Arzoumanian, et al.Archives of Internal Medicine|May 7, 1998
The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative GroupJ R Leclerc, M Gent, J Hirsh, et al.Clinics in Chest Medicine|September 1, 1984
The diagnosis of clinically suspected venous thrombosisR D Hull, G E Raskob, J R LeClerc, et al.Journal of Geriatric Oncology|March 9, 2024
A structured oral chemotherapy teaching tool to improve adherence in adults with multiple myeloma: A pilot randomized controlled trialImran Haider, Gregory R Pond, Ruthanne Cameron, et al.Stroke|August 6, 2000
Hemostatic markers in patients at risk of cerebral ischemiaR Côté, C Wolfson, S Solymoss, et al.Thrombosis and Haemostasis|April 2, 1992
Prevention of deep vein thrombosis after major knee surgery--a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placeboJ R Leclerc, W H Geerts, L Desjardins, et al.Pageof 3